This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

There is a consensus about the beneficial effect of prophylactic and therapeutic use of aspirin in reducing the mortality of those who have had atherosclerotic heart attacks and strokes. The American Heart Association and the Food and Drug Administration recommend that aspirin, 75 to 325 mg/d, be given to those who have had ischemic cardiac or neurologic symptoms.¹ Whether aspirin has value in lessening the occurrence of such symptoms in the asymptomatic elderly remains questionable. However, the literature contains evidence that some patients admitted to intensive care units with acute respiratory distress syndrome (ARDS) have inadvertently medicated themselves with too much aspirin for intercurrent illnesses.^2-3

I have seen 2 aging adults with severe bouts of ARDS, both of whom were treated for severe pulmonary edema and multiorgan failure. Both had been taking aspirin, with one patient receiving about 325 mg/d and the other, about 650 mg/d, and the patients increased . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?